Life sciences real estate investment in Asia is shifting focus

Private equity real estate’s pivot to R&D has been a much more recent trend in the region compared with the West, as two high-profile investments show.

30 June 2022•3 mins read

Opinion Allocation Strategy Friday Letter

Related articles

alt

Managers should get ahead of an emerging branding crisis

27 August 2026 · 3 mins read

alt

Is Goldman late to the net-lease party?

20 August 2026 · 3 mins read

alt

Family offices are taking the specialist route to third-party expansion

13 August 2026 · 3 mins read

alt

Blue Owl has plenty of room to grow in Europe

6 August 2026 · 3 mins read

alt

Apollo has made a surprising pivot in real estate fundraising

30 July 2026 · 3 mins read

alt

Investors committing to real estate funds face a key constraint

23 July 2026 · 2 mins read

alt

PERE’s relaunch – The editors’ take

16 July 2026 · 3 mins read

motif